Every earnings call for SURAKSHA — management tone, guidance, KPIs and promise tracking, quarter by quarter.
SURAKSHA · 5 transcripts · Healthcare · latest Q4 FY26Revenue (FY26) 3136 million (+22% YoY); EBITDA (FY26) 986 million (+16% YoY); EBITDA Margin (FY26) 31.8%. FY26 Revenue from operations grew 23.1% YoY to INR3104.1 million.
Read full transcript & analysisEBITDA (Q3 FY26) 237.82 million (+26% YoY); EBITDA Margin (Q3 FY26) 30.6%; PAT (Q3 FY26) 72.41 million. Total income grew 30.3% YoY to INR 783.09 million in Q3 FY26.
Read full transcript & analysisQ2 Revenue ₹80 cr (+17% YoY); Q2 EBITDA ₹25 cr (+2% YoY); Q2 EBITDA Margin 31.7%. Q2 FY26 total income grew 16.9% YoY to INR79.58 crores.
Read full transcript & analysisEBITDA ₹25 cr (+14% YoY); EBITDA Margin 33.97%; PAT ₹9 cr (+20% YoY). Total income grew 18.83% YoY to ₹73.49 crores.
Read full transcript & analysisEBITDA (FY25) ₹85 cr (+16% YoY); EBITDA Margin (FY25) 34.0%; PAT (FY25) ₹31 cr (+34% YoY). FY25 Total Income grew 15% YoY to ₹255.94 crores.
Read full transcript & analysis